# Clinuvel Pharmaceuticals (CUVL) — News

CUVL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cuvl/news

## Recent headlines

- [Clinuvel completed development of Zerokin](https://www.ainvest.com/news/clinuvel-completed-development-zerokin-2609) — AInvest Wire, Sep 8, 2026
  Clinuvel Pharmaceuticals has announced the completion of development for its drug candidate Zerokin, marking a significant milestone in the company’s pipeline[1]. The final phase of clinical trials has been successfully concluded, with the data meeting the required endpoints for regulatory…
- [Clinuvel Pharmaceuticals Ltd - Clinuvel's ADS commences trading on Nasdaq](https://www.ainvest.com/news/clinuvel-pharmaceuticals-clinuvel-ads-commences-trading-nasdaq-2607) — AInvest Wire, Jul 20, 2026
  On July 20, 2026, Clinuvel Pharmaceuticals Ltd announced that its American Depositary Shares (ADS) will commence trading on Nasdaq . This development marks a significant milestone for the Australian-based pharmaceutical company, which will now have access to a broader pool of international…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).